(Q44142876)

30 November 2017

title

Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide (English)

1 reference

30 November 2017

1 reference

6

Farhad Ravandi

1 reference

30 November 2017

7

Saverio Minucci

1 reference

30 November 2017

Amit Verma

1

1 reference

30 November 2017

Mani Mohindru

2

1 reference

30 November 2017

Dilip K Deb

3

1 reference

30 November 2017

Antonella Sassano

4

1 reference

30 November 2017

Suman Kambhampati

5

1 reference

30 November 2017

Dhananjaya V Kalvakolanu

8

1 reference

30 November 2017

Leonidas C Platanias

9

1 reference

30 November 2017

language of work or name

English

0 references

publication date

17 September 2002

1 reference

Journal of Biological Chemistry

30 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 November 2017

volume

277

1 reference

30 November 2017

issue

47

1 reference

30 November 2017

page(s)

44988-44995

1 reference

Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Acute promyelocytic leukemia: evolving therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Arsenic trioxide: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

The p38 signal transduction pathway: activation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

p38-2, a novel mitogen-activated protein kinase with distinct properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

The primary structure of p38 gamma: a new member of p38 group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Osmotic regulation of cytokine synthesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Activation of the p38 mitogen-activated protein kinase by type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Rho Family GTPases Regulate p38 Mitogen-activated Protein Kinase through the Downstream Mediator Pak1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Arsenic compounds as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Structural basis of inhibitor selectivity in MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Structural organization of the bcr gene and its role in the Ph' translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Multifaceted approach to the treatment of bcr-abl-positive leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

Expanding the use of arsenic trioxide: leukemias and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207176200

21 January 2018

Identifiers

DOI

10.1074/JBC.M207176200

1 reference

30 November 2017

1 reference